---
schema_version: "secwatch.filing_event.v1"
accession: "0000105770-21-000080"
form_type: "8-K"
ticker: "WST"
cik: "0000105770"
company_name: "WEST PHARMACEUTICAL SERVICES INC"
filed_at: "2021-10-28T23:59:59+00:00"
generated_at: "2026-06-28T16:32:01.708235+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# West Pharma Q3 net sales $706.5M (+28.9%); adj. EPS $2.06 (+79%); raises FY guidance, dividend up 5.9%

## Summary
- Net sales of $706.5M grew 28.9% (organic +27.9%); reported diluted EPS $2.31 (+112%).
- Adjusted diluted EPS of $2.06 increased 79% YoY.
- Proprietary Products segment sales grew 36.9% to $577M; HVP portfolio led growth.
- Full-year 2021 net sales guidance raised to $2.800-$2.810B; adj. EPS to $8.40-$8.50.
- Quarterly dividend increased 5.9% to $0.18/share, payable Nov 17, 2021.

## SEC filing metadata
- accession: 0000105770-21-000080
- form_type: 8-K
- ticker: WST
- cik: 0000105770
- company_name: WEST PHARMACEUTICAL SERVICES INC
- filed_at: 2021-10-28T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/105770/000010577021000080/0000105770-21-000080-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/105770/000010577021000080/wst-20211028.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000105770-21-000080
- JSON: https://secwatch.observer/filing/0000105770-21-000080.json
- Plain text: https://secwatch.observer/filing/0000105770-21-000080.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.